109 related articles for article (PubMed ID: 11166952)
1. Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer's disease patients.
Rösler N; Wichart I; Jellinger KA
Neurosci Lett; 2001 Feb; 299(1-2):117-20. PubMed ID: 11166952
[TBL] [Abstract][Full Text] [Related]
2. Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin-6 in Alzheimer's disease patients.
Rösler N; Wichart I; Jellinger KA
Acta Neurol Scand; 2001 Feb; 103(2):126-30. PubMed ID: 11227132
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.
Johansson P; Almqvist EG; Wallin A; Johansson JO; Andreasson U; Blennow K; Zetterberg H; Svensson J
Neurosci Lett; 2015 Nov; 609():58-62. PubMed ID: 26453765
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
Appleyard ME; McDonald B
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease.
Molina JA; Jiménez-Jiménez FJ; Vargas C; Gómez P; de Bustos F; Gómez-Escalonilla C; Zurdo M; Tallón A; Martínez-Salio A; Porta-Etessam J; Villanueva C; Arenas J
Acta Neurol Scand; 2002 Dec; 106(6):347-50. PubMed ID: 12460139
[TBL] [Abstract][Full Text] [Related]
6. Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?
Tumani H; Shen G; Peter JB; Brück W
Arch Neurol; 1999 Oct; 56(10):1241-6. PubMed ID: 10520940
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
de la Monte SM; Volicer L; Hauser SL; Wands JR
Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
[TBL] [Abstract][Full Text] [Related]
8. Measurement of laminins in the cerebrospinal fluid obtained from patients with Alzheimer's disease and vascular dementia using a modified enzyme-linked immunosorbent assay.
Matsuda K; Tashiro K; Hayashi Y; Monji A; Yoshida I; Mitsuyama Y
Dement Geriatr Cogn Disord; 2002; 14(3):113-22. PubMed ID: 12218253
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
[TBL] [Abstract][Full Text] [Related]
10. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
[TBL] [Abstract][Full Text] [Related]
11. Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.
Takeda S; Commins C; DeVos SL; Nobuhara CK; Wegmann S; Roe AD; Costantino I; Fan Z; Nicholls SB; Sherman AE; Trisini Lipsanopoulos AT; Scherzer CR; Carlson GA; Pitstick R; Peskind ER; Raskind MA; Li G; Montine TJ; Frosch MP; Hyman BT
Ann Neurol; 2016 Sep; 80(3):355-67. PubMed ID: 27351289
[TBL] [Abstract][Full Text] [Related]
12. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
13. Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease.
Rösler N; Wichart I; Jellinger KA
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):452-4. PubMed ID: 8774418
[TBL] [Abstract][Full Text] [Related]
14. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease.
Harigaya Y; Shoji M; Nakamura T; Matsubara E; Hosoda K; Hirai S
Intern Med; 1995 Jun; 34(6):481-4. PubMed ID: 7549128
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes.
Pomeraniec IJ; Bond AE; Lopes MB; Jane JA
J Neurosurg; 2016 Feb; 124(2):382-8. PubMed ID: 26339853
[TBL] [Abstract][Full Text] [Related]
18. Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.
Tautvydaitė D; Kukreja D; Antonietti JP; Henry H; von Gunten A; Popp J
Alzheimers Res Ther; 2017 Feb; 9(1):6. PubMed ID: 28153054
[TBL] [Abstract][Full Text] [Related]
19. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.
Carmona-Iragui M; Santos T; Videla S; Fernández S; Benejam B; Videla L; Alcolea D; Blennow K; Blesa R; Lleó A; Fortea J
J Alzheimers Dis; 2017; 55(4):1489-1496. PubMed ID: 27858714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
